Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort - Grigoriadis, Dionysios; Sackey, Ege; Riches, Katie; van Zanten, Malou; Brice, Glen; England, Ruth; Mills, Mike; Dobbins, Sara E; Lipoedema Consortium, Genomics England Research Consortium; Jeffery, Steve; Dong, Liang; Savage, David B.; et al. (medRxiv, 2021)
Lipoedema is a chronic adipose tissue disorder mainly affecting women, causing excess subcutaneous fat deposition on the lower limbs with pain and tenderness. There is often a family history of lipoedema, suggesting a genetic origin, but the contribution of genetics is currently unclear. A tightly phenotyped cohort of 200 lipoedema patients was recruited from two UK specialist clinics. Objective clinical characteristics and measures of quality of life data were obtained. In an attempt to understand the genetic architecture of the disease better, genome-wide single nucleotide polymorphism (SNP) genotype data were obtained, and a genome wide association study (GWAS) performed on 130 of the recruits. The analysis revealed genetic loci suggestively associated with the lipoedema phenotype, with further support provided by an independent cohort taken from the 100,000 Genomes Project. Top SNPs included loci associated with lipoma formation, biosynthesis of hormones and lipid hydroxylation. Exactly how these SNPs relate to a lipoedema disease mechanism is not yet understood but the findings are consistent with existing fat and hormone hypotheses. This first GWAS of a UK lipoedema cohort has identified genetic regions of suggestive association with the disease. Further replication of these findings in different populations is warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by Lipedema Foundation (https://www.lipedema.org/) LF#006 (KG and PO), the Wellcome Trust (https://wellcome.org/) WT107064 (DBS), and the MRC Metabolic Disease Unit, and The National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and NIHR Rare Disease Translational Research Collaboration (https://www.mrl.ims.cam.ac.uk/mrc-metabolic-diseases-unit/) MRC_MC_UU_12012.1 (DBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study Genes and Gene Function in Lipoedema was approved by the Fulham NRESCommittee.London (HEALTH RESEARCH AUTHORITY; nrescommittee.londonfulham@ nhs.net) Approval number: IRAS 177674; REC 16/LO/0005.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUpon acceptance of the manuscript for publication in a journal the full raw SNP array data will be uploaded to EGA where it will be available for researchers who meet the criteria for access to confidential data. A summary of the GWAS data will also be made available through a FIGSHARE repository for anyone to access.